Plunkett Research Online: ProMetic Life Sciences Inc

PROMETIC LIFE SCIENCES INC (PLI:TSE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ProMetic Life Sciences, Inc. is a drug developer and provider in the fields of hematology, oncology and nephrology. The company divides its activities in two fields: protein technologies and therapeutics. Protein technologies focuses on bioseparation and plasma-derived biotherapeutics. The biosep.....



ProMetic Life Sciences Inc
Ticker: PLI
Exchange: TSE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 450 781-0115
Fax: 450 781-4477
Address: 440, Boulevard Armand-Frappier
Suite 300
Laval, QC H7V 4B4 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Plasma Technologies
ContactsDescription
Pierre LaurinCEO/Director/Founder/President
John MoranChief Medical Officer/Director
See More
ProMetic Life Sciences, Inc. is a drug developer and provider in the fields of hematology, oncology and nephrology. The company divides its activities in two fields: protein technologies and therapeutics. Protein technologies focuses on bioseparation and plasma-derived biotherapeutics. The biosep.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
ProMetic BioSeparations Ltd
ProMetic BioSciences Inc
PBI-4050
Plasminogen
IVIG
Ryplazim
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: